Business Description
Founded in 2011 and based in Vancouver, Washington, Absci Corporation is a clinical-stage company focused on discovering and developing antibody-based medicines. The company is currently advancing several drug candidates targeting conditions such as inflammatory bowel disease, hair loss, and cancer. To support its research, Absci works alongside a range of partners including Memorial Sloan Kettering Cancer Center, Twist Bioscience, Oracle Corporation, and Advanced Micro Devices.
